These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31912215)

  • 21. A New Theory for Ménière's Disease: Detached Saccular Otoconia.
    Hornibrook J; Bird P
    Otolaryngol Head Neck Surg; 2017 Feb; 156(2):350-352. PubMed ID: 28145833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ménière's disease.
    Minor LB; Schessel DA; Carey JP
    Curr Opin Neurol; 2004 Feb; 17(1):9-16. PubMed ID: 15090872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient Perceptions of Effectiveness in Treatments for Menière's Disease: a National Survey in Italy.
    Ward B; Wettstein V; Golding J; Corallo G; Nuti D; Trabalzini F; Mandala M
    J Int Adv Otol; 2019 Apr; 15(1):112-117. PubMed ID: 31058600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meniere's disease and endolymphatic hydrops without Meniere's symptoms: temporal bone histopathology.
    Vasama JP; Linthicum FH
    Acta Otolaryngol; 1999; 119(3):297-301. PubMed ID: 10380731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endolymphatic hydrops in Meniere's disease detected by MRI after intratympanic administration of gadolinium: comparison with sudden deafness.
    Horii A; Osaki Y; Kitahara T; Imai T; Uno A; Nishiike S; Fujita N; Inohara H
    Acta Otolaryngol; 2011 Jun; 131(6):602-9. PubMed ID: 21344957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral theory for Ménière's disease and endolymphatic hydrops: overview and new therapeutic options for viral labyrinthitis.
    Arenberg IK; Lemke C; Shambaugh GE
    Ann N Y Acad Sci; 1997 Dec; 830():306-13. PubMed ID: 9616689
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationship Between Audio-Vestibular Functional Tests and Inner Ear MRI in Meniere's Disease.
    Quatre R; Attyé A; Karkas A; Job A; Dumas G; Schmerber S
    Ear Hear; 2019; 40(1):168-176. PubMed ID: 29698363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M; Marsan J; Schramm D; Robichaud J
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endolymphatic hydrops in asymptomatic ears in unilateral Ménière's disease.
    Friedrichs I; Thornton AR
    Laryngoscope; 2001 May; 111(5):857-60. PubMed ID: 11359166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endolymphatic hydrops and therapeutic effects are visualized in 'atypical' Meniere's disease.
    Miyagawa M; Fukuoka H; Tsukada K; Oguchi T; Takumi Y; Sugiura M; Ueda H; Kadoya M; Usami S
    Acta Otolaryngol; 2009 Nov; 129(11):1326-9. PubMed ID: 19863332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on intratympanic gentamicin for Meniere's disease.
    Blakley BW
    Laryngoscope; 2000 Feb; 110(2 Pt 1):236-40. PubMed ID: 10680922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transtympanic gentamicin perfusion for the treatment of Meniere's disease.
    Schwaber MK
    Otolaryngol Clin North Am; 2002 Apr; 35(2):287-95, vi. PubMed ID: 12391619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops.
    Gürkov R; Pyykö I; Zou J; Kentala E
    J Neurol; 2016 Apr; 263 Suppl 1():S71-81. PubMed ID: 27083887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Follow-up assessment of intratympanic gentamicin therapy and Saccotomia in Menière's Disease].
    Tauber S; Jäger L; Issing WJ
    Laryngorhinootologie; 2002 May; 81(5):335-41. PubMed ID: 12001022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menière's disease and endolymphatic hydrops: clinical-histopathological correlations.
    Fraysse BG; Alonso A; House WF
    Ann Otol Rhinol Laryngol Suppl; 1980; 89(6 Pt 3):2-22. PubMed ID: 6779694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to Letter to the Editor: "Effectiveness of Intratympanic Administration of Gentamicin in Unilateral meniÈre's Disease".
    Yaz F; Ziylan F; Smeeing DPJ; Thomeer HGXM
    Otol Neurotol; 2020 Sep; 41(8):e1067-e1068. PubMed ID: 33169954
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?
    Merchant SN; Adams JC; Nadol JB
    Otol Neurotol; 2005 Jan; 26(1):74-81. PubMed ID: 15699723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endolymphatic hydrops in Ménière's disease: cause, consequence, or epiphenomenon?
    Foster CA; Breeze RE
    Otol Neurotol; 2013 Sep; 34(7):1210-4. PubMed ID: 23921917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.